
Inhibikase Therapeutics, Inc.
IKTHealthcare|Biotechnology|US
$1.50
+0.06 (+4.17%)
DCF Value
$1.41
Tangible Book / Share
$0.88
Cash / Share
$0.91
Next Earnings Report
Nov 13, 2026
EPS est. -$0.11 · Revenue est. $187.5K
Financing Filings (last 12 months)
3
Shelf registrations / offering prospectuses — latest Dec 19, 2025 (424B5). Possible dilution.
Upcoming Data Readouts (1)
Jun 2029
Est. completion
P3Pulmonary Arterial Hypertension
An Adaptive Program of IKT-001 in Pulmonary Arterial Hypertension (PAH)
NCT07365332n=486
Recent Press Releases
Inhibikase Therapeutics Announces Participation in Upcoming Investor Conferences During November 2026
Oct 27, 2026 · GlobeNewsWire
Inhibikase Therapeutics Appoints Scott Wasserman to Board of Directors
Oct 20, 2026 · GlobeNewsWire
Inhibikase Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Oct 2, 2026 · GlobeNewsWire
Inhibikase Therapeutics Announces Second Quarter 2026 Financial Results and Highlights Recent Activity
Aug 11, 2026 · GlobeNewsWire
SEC Filings (83)
Last two years from EDGAR. Insider Form 4s are on the Ownership tab.
| Filed | Form | What it is | Links |
|---|---|---|---|
| Oct 20, 2026 | 8-K | Material event | DocumentIndex |
| Sep 8, 2026 | 8-K | Material event | DocumentIndex |
| Aug 26, 2026 | 8-K | Material event | DocumentIndex |
| Aug 14, 2026 | SC 13G/A | Passive 5%+ stake | DocumentIndex |
| Aug 14, 2026 | SC 13G/A | Passive 5%+ stake | DocumentIndex |
| Aug 13, 2026 | SC 13G/A | Passive 5%+ stake | DocumentIndex |
| Aug 11, 2026 | S-8 | Employee stock plan | DocumentIndex |
| Aug 11, 2026 | 10-Q | Quarterly report | DocumentIndex |
| Aug 11, 2026 | 8-K | Material event | DocumentIndex |
| Jul 31, 2026 | SC 13G/A | Passive 5%+ stake | DocumentIndex |
| Jul 29, 2026 | 8-K | Material event | DocumentIndex |
| Jul 28, 2026 | SC 13G | Passive 5%+ stake | DocumentIndex |
| Jul 23, 2026 | 8-K | Material event | DocumentIndex |
| Jul 17, 2026 | SC 13G | Passive 5%+ stake | DocumentIndex |
| Jul 14, 2026 | 8-K | Material event | DocumentIndex |
| Jun 29, 2026 | 8-K | Material event | DocumentIndex |
| May 15, 2026 | SC 13G/A | Passive 5%+ stake | DocumentIndex |
| May 15, 2026 | SC 13G/A | Passive 5%+ stake | DocumentIndex |
| May 15, 2026 | SC 13G/A | Passive 5%+ stake | DocumentIndex |
| May 15, 2026 | SC 13G/A | Passive 5%+ stake | DocumentIndex |
| May 12, 2026 | 10-Q | Quarterly report | DocumentIndex |
| May 12, 2026 | 8-K | Material event | DocumentIndex |
| Apr 30, 2026 | ARS | Annual report to holders | DocumentIndex |
| Apr 30, 2026 | DEFA14A | Proxy / shareholder vote | DocumentIndex |
| Apr 30, 2026 | DEF 14A | Proxy / shareholder vote | DocumentIndex |
| Apr 20, 2026 | PRE 14A | Proxy / shareholder vote | DocumentIndex |
| Apr 7, 2026 | 8-K | Material event | DocumentIndex |
| Mar 26, 2026 | S-8 | Employee stock plan | DocumentIndex |
| Mar 26, 2026 | 10-K | Annual report | DocumentIndex |
| Mar 26, 2026 | 8-K | Material event | DocumentIndex |
| Feb 17, 2026 | SC 13G/A | Passive 5%+ stake | DocumentIndex |
| Feb 17, 2026 | SC 13G/A | Passive 5%+ stake | DocumentIndex |
| Feb 17, 2026 | SC 13G/A | Passive 5%+ stake | DocumentIndex |
| Feb 13, 2026 | SC 13G/A | Passive 5%+ stake | DocumentIndex |
| Feb 13, 2026 | SC 13G/A | Passive 5%+ stake | DocumentIndex |
| Dec 31, 2025 | SC 13G | Passive 5%+ stake | DocumentIndex |
| Dec 19, 2025 | 8-K | Material event | DocumentIndex |
| Dec 19, 2025 | 424B5 | Offering prospectus | DocumentIndex |
| Nov 21, 2025 | 8-K | Material event | DocumentIndex |
| Nov 21, 2025 | 424B5 | Offering prospectus | DocumentIndex |